B-cell lymphomas

CAR T-Cell Therapy is About to Become Available in Europe

CAR T-Cell Therapy is About to Become Available in Europe The European Medicines Agency has recommended the approval of what could soon be the first…

بیشتر بخوانید »

ASH: Anti-CD19 CAR T-cell Tx beneficial in B-cell lymphomas

(HealthDay)—Axicabtagene ciloleucel (axi-cel), an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy and autologous T cells that express a CD19-directed CAR (CTL019) are effective for…

بیشتر بخوانید »